Skip to main content
SpringerLink
Log in

Pronounced influence of presystemic metabolism on the metabolic disposition of imrecoxib in renally impaired patients

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chen XH, Bai JY, Shen F, Bai AP, Guo ZR, Cheng GF (2004) Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect. Acta Pharmacol Sin 25(7):927–931

    PubMed  Google Scholar 

  2. Pei Q, Xie JL, Huang J, Liu WY, Yang XY, Wang Y, Li W, Tan HY, Zhang H, Yang GP (2019) Pharmacokinetic study of imrecoxib in patients with renal insufficiency. Eur J Clin Pharmacol 75(10):1355–1360

    Article  CAS  Google Scholar 

  3. Li Q, Huang HH, Dong Y, Zhong DF (2005) Investigation on the hydroxylation metabolism of imrecoxib in vitro by using recombinant human CYPs. Yao Xue Xue Bao 40(10):912–925 (in Chinese)

    CAS  PubMed  Google Scholar 

  4. Xu H, Zhang Y, Sun Y, Zhang P, Chu F, Guo Z, Zhang H, Zhong D (2006) Metabolism and excretion of imrecoxib in rat. Xenobiotica. 36(5):441–455

    Article  Google Scholar 

  5. Hou X, Zhou J, Yu S, Zhou L, Zhang Y, Zhong D, Chen X (2018) Differences in the in vivo and in vitro metabolism of Imrecoxib in humans: formation of the rate-limiting aldehyde intermediate. Drug Metab Dispos 46(9):1320–1328

    Article  CAS  Google Scholar 

  6. Feng Z, Chu F, Guo Z, Sun P (2009) Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib. Bioorg Med Chem Lett 19:2270–2272

    Article  CAS  Google Scholar 

  7. Yeung CK, Shen DD, Thummel KE, Himmelfarb J (2014) Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport. Kidney Int 85(3):522–528

    Article  CAS  Google Scholar 

  8. Miners JO, Yang X, Knights KM, Zhang L (2017) The role of the kidney in drug elimination: transport, metabolism, and the impact of kidney disease on drug clearance. Clin Pharmacol Ther 102(3):436–449

    Article  CAS  Google Scholar 

  9. Elston AC, Bayliss MK, Park GR (1993) Effect of renal failure on drug metabolism by the liver. Br J Anaesth 71(2):282–290

    Article  CAS  Google Scholar 

  10. Srinivas NR (2010) Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives. Arzneimittelforschung 60(12):731–748

    CAS  PubMed  Google Scholar 

  11. Philips BJ, Lane K, Dixon J, Macphee I (2014) The effects of acute renal failure on drug metabolism. Expert Opin Drug Metab Toxicol 10(1):11–23

    Article  CAS  Google Scholar 

  12. Lalande L, Charpiat B, Leboucher G, Tod M (2014) Consequences of renal failure on non-renal clearance of drugs. Clin Pharmacokinet 53(6):521–532

    Article  CAS  Google Scholar 

  13. Giri P, Patel H, Srinivas NR (2019) Use of cocktail probe drugs for indexing cytochrome P450 enzymes in clinical pharmacology studies - review of case studies. Drug Metab Lett 13(1):3–18

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Innovation and Technology, Jubilant Life Sciences, Sector 59 (D-10), Noida, Uttar Pradesh, India

    Nuggehally R. Srinivas

  2. Kenox Pharmaceuticals Inc, 11 Deerpark Dr, Suite 128, Princeton Corporate Plaza, Monmouth Junction, NJ, 08852, USA

    Nuggehally R. Srinivas

Authors
  1. Nuggehally R. Srinivas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nuggehally R. Srinivas.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Srinivas, N.R. Pronounced influence of presystemic metabolism on the metabolic disposition of imrecoxib in renally impaired patients. Eur J Clin Pharmacol 76, 469–471 (2020). https://doi.org/10.1007/s00228-019-02824-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-019-02824-9

Search

Navigation